Japan Vietnam Medical Investment and Development JSC (HOSE:JVC)
Vietnam · Delayed Price · Currency is VND 2,790.00
+10.00 (0.36%)
At close: Oct 14, 2026
HOSE:JVC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
| 313,875 | 685,126 | 427,501 | 380,251 | 390,376 | 517,501 | |
Market Cap Growth | -67.67% | 60.26% | 12.43% | -2.59% | -24.57% | -77.67% |
Enterprise Value | 440,216 | 962,285 | 425,722 | 378,472 | 469,500 | 596,625 |
Last Close Price | 2790.00 | 6090.00 | 3800.00 | 3380.00 | 3470.00 | 4600.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
PE Ratio | 6.22 | 13.72 | 10.61 | 7.22 | - | - |
Forward PE | - | 9.64 | 9.64 | 9.64 | 9.64 | 9.64 |
PS Ratio | 0.42 | 0.90 | 0.70 | 0.66 | 0.78 | 1.02 |
PB Ratio | 0.48 | 1.09 | 0.79 | 0.76 | 0.74 | 0.93 |
P/TBV Ratio | 0.51 | 1.16 | 0.79 | 0.76 | 0.74 | 0.93 |
P/FCF Ratio | 1.24 | - | 6.18 | - | 11.64 | - |
P/OCF Ratio | 1.15 | - | 4.99 | - | 5.13 | - |
PEG Ratio | - | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
EV/Sales Ratio | 0.59 | 1.26 | 0.70 | 0.66 | 0.94 | 1.18 |
EV/EBITDA Ratio | 5.08 | 12.46 | 5.93 | 5.06 | 10.94 | - |
EV/EBIT Ratio | 7.02 | 18.23 | 11.66 | 13.86 | - | - |
EV/FCF Ratio | 1.73 | - | 6.16 | - | 14.00 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Debt / Equity Ratio | 0.34 | 0.48 | 0.26 | 0.19 | 0.07 | 0.09 |
Debt / EBITDA Ratio | 2.60 | 3.92 | 1.96 | 1.24 | 0.83 | - |
Debt / FCF Ratio | 0.89 | - | 2.04 | - | 1.07 | - |
Net Debt / Equity Ratio | 0.14 | 0.44 | 0.23 | -0.12 | 0.00 | 0.06 |
Net Debt / EBITDA Ratio | 1.04 | 3.55 | 1.69 | -0.81 | -0.04 | -0.03 |
Net Debt / FCF Ratio | 0.35 | -2.10 | 1.75 | 1.22 | -0.05 | -0.11 |
Asset Turnover | 0.78 | 0.80 | 0.81 | - | 0.64 | 0.30 |
Inventory Turnover | 3.75 | 4.48 | 4.51 | - | 3.40 | 1.98 |
Quick Ratio | 1.00 | 1.14 | 1.33 | 2.23 | -2.00 | -1.93 |
Current Ratio | 1.54 | 1.79 | 1.95 | 2.86 | 1.66 | 2.11 |
Return on Equity (ROE) | 8.14% | 8.57% | 7.76% | - | -5.86% | -109.10% |
Return on Assets (ROA) | 4.10% | 3.47% | 3.01% | - | -2.12% | -43.91% |
Return on Invested Capital (ROIC) | 5.79% | 5.50% | 4.55% | 5.35% | -4.80% | -113.61% |
Return on Capital Employed (ROCE) | 9.20% | 8.00% | 6.80% | 5.40% | -4.70% | -175.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 |
Earnings Yield | 16.09% | 7.29% | 9.42% | 13.84% | -8.12% | -258.12% |
FCF Yield | 80.96% | -19.03% | 16.18% | -13.11% | 8.59% | -63.35% |
Buyback Yield / Dilution | - | - | - | - | - | -43.62% |
Total Shareholder Return | 16.29% | - | - | - | - | -43.62% |